146 related articles for article (PubMed ID: 24953309)
1. Baseline and follow-up association of the MAX-PC in Men with newly diagnosed prostate cancer.
Tavlarides AM; Ames SC; Thiel DD; Diehl NN; Parker AS
Psychooncology; 2015 Apr; 24(4):451-7. PubMed ID: 24953309
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer.
Tavlarides AM; Ames SC; Diehl NN; Joseph RW; Castle EP; Thiel DD; Broderick GA; Parker AS
Psychooncology; 2013 Jun; 22(6):1328-35. PubMed ID: 22855322
[TBL] [Abstract][Full Text] [Related]
3. Health related quality of life and direct medical care cost in newly diagnosed younger men with prostate cancer.
Jayadevappa R; Bloom BS; Chhatre S; Fomberstein KM; Wein AJ; Malkowicz SB
J Urol; 2005 Sep; 174(3):1059-64; discussion 1064. PubMed ID: 16094058
[TBL] [Abstract][Full Text] [Related]
4. Italian cultural adaptation of the Memorial Anxiety for Prostate Cancer scale for the population of men on active surveillance.
Alvisi MF; Repetto C; Rancati T; Badenchini F; Magnani T; Marenghi C; Villa S; Nicolai N; Salvioni R; Avuzzi B; Valdagni R; Bellardita L;
Tumori; 2018 Jun; 104(3):172-178. PubMed ID: 28623635
[TBL] [Abstract][Full Text] [Related]
5. Assessing cancer-specific anxiety in Chinese men with prostate cancer: psychometric evaluation of the Chinese version of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC).
Huang Q; Jiang P; Zhang Z; Luo J; Dai Y; Zheng L; Wang W
Support Care Cancer; 2017 Dec; 25(12):3683-3690. PubMed ID: 28643193
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer-related anxiety in long-term survivors after radical prostatectomy.
Meissner VH; Herkommer K; Marten-Mittag B; Gschwend JE; Dinkel A
J Cancer Surviv; 2017 Dec; 11(6):800-807. PubMed ID: 28528448
[TBL] [Abstract][Full Text] [Related]
7. Comparison of patient-reported quality of life outcome questionnaire response rates between patients treated surgically for renal cell carcinoma and prostate carcinoma.
Thiel DD; Davidiuk AJ; Broderick GA; Arnold M; Diehl N; Tavlarides A; Custer K; Parker AS
BMC Urol; 2015 Jul; 15():58. PubMed ID: 26126615
[TBL] [Abstract][Full Text] [Related]
8. The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer.
Roth AJ; Rosenfeld B; Kornblith AB; Gibson C; Scher HI; Curley-Smart T; Holland JC; Breitbart W
Cancer; 2003 Jun; 97(11):2910-8. PubMed ID: 12767107
[TBL] [Abstract][Full Text] [Related]
9. Investigating the psychological impact of active surveillance or active treatment in newly diagnosed favorable-risk prostate cancer patients: A 9-month longitudinal study.
Ruane-McAteer E; Porter S; O'Sullivan J; Dempster M; Prue G
Psychooncology; 2019 Aug; 28(8):1743-1752. PubMed ID: 31243872
[TBL] [Abstract][Full Text] [Related]
10. Assessing anxiety in Black men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC).
Nelson CJ; Starr TD; Macchia RJ; Hyacinthe L; Friedman S; Roth AJ
Support Care Cancer; 2016 Jul; 24(7):2905-11. PubMed ID: 26847348
[TBL] [Abstract][Full Text] [Related]
11. Determining the optimal cut-off scores for the Chinese version of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC).
Huang Q; Jiang P; Ding Y; Zheng Y; Zheng L; Luo J; Dai Y; Wu F; Wang W
Health Qual Life Outcomes; 2023 Dec; 21(1):129. PubMed ID: 38041120
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels.
Venderbos LD; van den Bergh RC; Roobol MJ; Schröder FH; Essink-Bot ML; Bangma CH; Steyerberg EW; Korfage IJ
Psychooncology; 2015 Mar; 24(3):348-54. PubMed ID: 25138075
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of health-related quality-of-life outcomes for patients with low-risk prostate cancer managed by active surveillance or radiation therapy.
Banerji JS; Hurwitz LM; Cullen J; Wolff EM; Levie KE; Rosner IL; Brand TC; LʼEsperance JO; Sterbis JR; Porter CR
Urol Oncol; 2017 May; 35(5):234-242. PubMed ID: 28110975
[TBL] [Abstract][Full Text] [Related]
14. Clinical Use of Expanded Prostate Cancer Index Composite for Clinical Practice to Assess Patient Reported Prostate Cancer Quality of Life Following Robot-Assisted Radical Prostatectomy.
Wagner AA; Cheng PJ; Carneiro A; Dovirak O; Khosla A; Taylor KN; Crociani CM; McAnally KC; Percy A; Dewey LE; Sanda MG; Chang P
J Urol; 2017 Jan; 197(1):109-114. PubMed ID: 27475967
[TBL] [Abstract][Full Text] [Related]
15. Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC).
Roth A; Nelson CJ; Rosenfeld B; Warshowski A; O'Shea N; Scher H; Holland JC; Slovin S; Curley-Smart T; Reynolds T; Breitbart W
Psychosomatics; 2006; 47(4):340-7. PubMed ID: 16844894
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life outcomes from a contemporary prostate cancer registry in a large diverse population.
Chien GW; Slezak JM; Harrison TN; Jung H; Gelfond JS; Zheng C; Wu E; Contreras R; Loo RK; Jacobsen SJ
BJU Int; 2017 Oct; 120(4):520-529. PubMed ID: 28425193
[TBL] [Abstract][Full Text] [Related]
17. Understanding the Major Factors Affecting Response Shift Effects on Health-Related Quality of Life: What the Then-Test Measures in a Longitudinal Prostate Cancer Registry.
Ten Ham RMT; Broering JM; Cooperberg MR; Carroll P; Wilson LS
Clin Genitourin Cancer; 2020 Feb; 18(1):e21-e27. PubMed ID: 31796344
[TBL] [Abstract][Full Text] [Related]
18. The association of cancer-specific anxiety with disease aggressiveness in men on active surveillance of prostate cancer.
Naha U; Freedland SJ; Abern MR; Moreira DM
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):335-340. PubMed ID: 32901094
[TBL] [Abstract][Full Text] [Related]
19. Patient- and Surgeon-Level Variation in Patient-Reported Sexual Function Outcomes Following Radical Prostatectomy Over 2 Years: Results From a Statewide Surgical Improvement Collaborative.
Agochukwu-Mmonu N; Qi J; Dunn RL; Montie J; Wittmann D; Miller D; Martin R; Kim T; Johnston WK; Peabody J
JAMA Surg; 2022 Feb; 157(2):136-144. PubMed ID: 34851369
[TBL] [Abstract][Full Text] [Related]
20. Expanded Prostate Cancer Index Composite-26 (EPIC-26) Online: Validation of an Internet-Based Instrument for Assessment of Health-Related Quality of Life After Treatment for Localized Prostate Cancer.
Einstein DJ; Patil D; Chipman J; Regan MM; Davis K; Crociani CM; Wagner AA; Sanda MG; Chang P
Urology; 2019 May; 127():53-60. PubMed ID: 30790648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
